Krensavage Asset Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-59,429
Closed -$2.23M 13
2019
Q3
$2.23M Buy
59,429
+51
+0.1% +$1.95K 0.85% 10
2019
Q2
$2.59M Sell
59,378
-2,679
-4% -$115K 0.84% 10
2019
Q1
$2.65M Sell
62,057
-2,458
-4% -$110K 0.72% 11
2018
Q4
$2.89M Sell
64,515
-9,743
-13% -$510K 0.98% 12
2018
Q3
$5.09M Sell
74,258
-108,244
-59% -$6.97M 1.31% 13
2018
Q2
$10.4M Sell
182,502
-218,898
-55% -$11.6M 2.67% 12
2018
Q1
$18.5M Buy
401,400
+6,385
+2% +$303K 4.49% 9
2017
Q4
$18.2M Sell
395,015
-83,606
-17% -$3.84M 5.69% 8
2017
Q3
$21.6M Sell
478,621
-92,343
-16% -$3.94M 6.72% 8
2017
Q2
$22.4M Sell
570,964
-13,600
-2% -$514K 6.81% 9
2017
Q1
$22.3M Buy
584,564
+19,772
+4% +$770K 7.18% 8
2016
Q4
$20.9M Sell
564,792
-11,493
-2% -$411K 7.49% 6
2016
Q3
$20M Buy
576,285
+1,079
+0.2% +$37.8K 7.22% 7
2016
Q2
$18.7M Buy
575,206
+12,917
+2% +$396K 6.74% 7
2016
Q1
$16.2M Sell
562,289
-2,663
-0.5% -$70.9K 5.8% 7
2015
Q4
$18.9M Buy
564,952
+29,009
+5% +$902K 6.02% 7
2015
Q3
$15.2M Buy
535,943
+99,700
+23% +$3.48M 5.52% 8
2015
Q2
$17.7M Buy
436,243
+132,093
+43% +$5.93M 6.66% 5
2015
Q1
$15M Buy
304,150
+36,700
+14% +$1.7M 6.82% 5
2014
Q4
$12.2M Buy
+267,450
New +$10.5M 6.78% 6

Other funds holding AVNS

Krensavage Asset Management's AVNS Position: Q4 2019 in Review

Krensavage Asset Management sold out of Avanos Medical (AVNS) in Q4 2019, closing a stake of 59,429 shares — an estimated $2.23M sold.

Krensavage Asset Management first reported a position in AVNS in Q4 2014 and held it in 20 quarters. The position peaked at $22.4M in Q2 2017. 293 funds tracked by Wall St. Rank hold AVNS as of Q4 2019.

  • Krensavage Asset Management reported no remaining Avanos Medical position as of Q4 2019 after selling out during the quarter.
  • Krensavage Asset Management sold 59,429 Avanos Medical shares in Q4 2019, an estimated $2.23M.
  • Krensavage Asset Management first reported a position in Avanos Medical in Q4 2014 and held it in 20 quarters.
  • Krensavage Asset Management's Avanos Medical position peaked at $22.4M in Q2 2017.
  • 293 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2019.

Based on Krensavage Asset Management's 13F filing for Q4 2019, filed 18 Feb 2020.